Avesthagen signs MoU with Manipal AcuNova for drug discovery

Bangalore, May 3 (UNI) Avesthagen and Manipal AcuNova Limited have joined hands to undertake drug discovery, pre-clinical, clinical research including regulatory matters A Memorandum of Understanding in this regard was signed recently, according to a release here today.

The partnership would enable the two companies to jointly provide a fully integrated platform from early discovery to filing approvals for new drugs. They would also collaborate in validation of Molecular Diagnostics kits and Product Co-development for delivering high quality, affordable and advanced diagnostic tests using molecular techniques to patients and healthcare industry.

Avesthagen is India's leading fully integrated systems biology company that works towards the convergence of food, pharma and population genetics leading to predictive preventive personalized healthcare, while Manipal AcuNova, on the other hand is a collaborative venture between the Manipal Education and Medical Group International India Private Ltd., and AcuNova Life Sciences Inc.

UNI